Trends in the incidence of chronic Philadelphia chromosome negative (Ph‐) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983–99
Open Access
- 15 July 2004
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 256 (2), 161-165
- https://doi.org/10.1111/j.1365-2796.2004.01357.x
Abstract
Objective. In the literature the incidence rates for the chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders (MPD) are known to vary extensively; only a few studies have, however, been concerned with incidence trends over time. Therefore, the aim of the present work was to investigate possible trends as regards incidence rates over time for Ph-MPD. Design. Herein, we carried out a retrospective population-based survey on the incidence of polycythaemia vera (PV), essential thrombocythae-mia (ET) and chronic idiopathic myelofibrosis (IMF), in the city of Göteborg (Sweden), covering the years 1983–99. Results. The study comprised 416 patients with Ph-MPD. There were 205 patients with PV, 153 patients with ET, 34 with IMF and 24 with unclassified MPD. The annual incidence for PV was 1.97 per 105 inhabitants; the corresponding figures for ET and IMF were 1.55 per 105 and 0.30 per 105 inhabitants, respectively. There was a significant increase in the annual incidence rate for ET (P = 0.008); this increase was significant for male subjects (P = 0.015) but did not reach significance for females (P = 0.118). No such increase over time was recorded as regards PV and IMF. Conclusions. The increasing annual incidence rate for ET is most possibly explained by the more frequent use of automated platelet counts whenever a patient consults a doctor. Thereby, an increasing number of patients with overt thrombocytosis of unknown origin are discovered and will be referred to specialists within the field of haematology for a correct diagnosis.Keywords
This publication has 16 references indexed in Scilit:
- Assessment of spleen size using gamma camera scintigraphy in newly diagnosed patients with essential thrombocythaemia and polycythaemia veraEuropean Journal of Haematology, 2009
- CONSORT statement: extension to cluster randomised trialsBMJ, 2004
- Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983-1992European Journal of Haematology, 2000
- Incidence, clinical features and outcome of essential thrombocythaemia in a well defined geographical areaEuropean Journal of Haematology, 2000
- Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted county study, 1976-1995American Journal of Hematology, 1999
- Diagnostic and Differential Criteria of Essential Thrombocythemia and Reactive ThrombocytosisLeukemia & Lymphoma, 1996
- Trends in the incidence of polycythemia vera among olmsted county, Minnesota residents, 1935–1989American Journal of Hematology, 1994
- Incidence of polycythemia vera in a defined populationEuropean Journal of Haematology, 1992
- High Incidence of Myeloproliferative Disorders in Ashkenazi Jews in Northern IsraelLeukemia & Lymphoma, 1992
- A Note on the Increased Risk of Polycythemia Vera in JewsBlood, 1971